PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
24-Dec-2021 Amerigo Scientific Launches KCC2 Ion Channel for Researchers Amerigo Scientific
24-Dec-2021 STEMart Announces Sensitization Testing for Medical Device STEMart
24-Dec-2021 CD Bioparticles Announces Offering of Polylactides for Researchers CD Bioparticles
24-Dec-2021 CD Bioparticles Launches New Polystyrene Latex Beads to Accelerate Bioresearch CD Bioparticles
23-Dec-2021 Creative Diagnostics Launches Immunohistochemistry Antibodies for Pathology Study Creative Diagnostics
23-Dec-2021 CD Formulation Offers Multiple Methods for Microbial Limit Test CD Formulation
20-Dec-2021 Transdermal and Microneedle Drug Delivery 2022 Virtual and Online event SMi Group
20-Dec-2021 Advancing AI Drug Discovery in Clinical Trials at SMi’s 3rd Annual AI in Drug Discovery Conference SMi Group
20-Dec-2021 SMi’s 10th Annual Pharmaceutical Microbiology UK Conference - A Virtual Conference with Online Access Only SMi Group
20-Dec-2021 Anticancer Bioscience Expands its R&D and Headquarters with a Relocation to Tianfu International Biotown, China Anticancer Bioscience
17-Dec-2021 Genoscience Pharma licences GNS561, its PPT-1 inhibitor, to GENFIT in cholangiocarcinoma indication in US/Canada and Europe Andrew Lloyd Associates
16-Dec-2021 Brainomix Closes £16M ($21.2M) Financing Round to Expand Its Proven AI-Enabled Platform Beyond Stroke Brainomix
16-Dec-2021 Immutep Advances IMP761 Manufacturing Immutep
16-Dec-2021 Profacgen Helps Accelerate GPCR Study with Various Services Profacgen
16-Dec-2021 BCI Pharma enters into strategic partnership with Mithra to identify novel therapy for endometriosis and cancer in women Andrew Lloyd Associates
15-Dec-2021 Depixus Raises EUR 30.6M (USD 35.4M) in Series A Financing Depixus
15-Dec-2021 Abzena Promotes Troy Wright to Senior Vice President and Global Head of Quality Abzena
15-Dec-2021 Contipharma launches saliva-based Omicron detecting PCR test in Africa Andrew Lloyd Associates
14-Dec-2021 AgeX Therapeutics to Collaborate With University of California, Irvine, on Research Program for Exosome-Based Therapies for Certain Brain Disorders AgeX Therapeutics
14-Dec-2021 Limbach Group adopts QuantaMatrix dRAST™ in routine clinical use Andrew Lloyd Associates